Entera Bio annual depreciation and amortization
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Depreciation & Amortization Growth & History (ENTX)
Entera Bio's depreciation and amortization was $30,000 for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30,000 | −$16,000 | −34.78% |
| 2024 | 2024-12-31 | $46,000 | −$10,000 | −17.86% |
| 2023 | 2023-12-31 | $56,000 | −$8,000 | −12.50% |
| 2022 | 2022-12-31 | $64,000 | $11,000 | +20.75% |
| 2021 | 2021-12-31 | $53,000 | −$172,000 | −76.44% |
| 2020 | 2020-12-31 | $225,000 | −$13,000 | −5.46% |
| 2019 | 2019-12-31 | $238,000 | $184,000 | +340.74% |
| 2018 | 2018-12-31 | $54,000 | $11,000 | +25.58% |
| 2017 | 2017-12-31 | $43,000 | $8,000 | +22.86% |
| 2016 | 2016-12-31 | $35,000 | — | — |
Entera Bio quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9,000 | $2,000 | +28.57% |
| Q1 2026 | 2026-03-31 | $7,000 | −$1,000 | −12.50% |
| Q4 2025 | 2025-12-31 | $7,000 | — | — |
| Q3 2025 | 2025-09-30 | $8,000 | −$3,000 | −27.27% |
| Q2 2025 | 2025-06-30 | $7,000 | −$4,000 | −36.36% |
| Q1 2025 | 2025-03-31 | $8,000 | −$5,000 | −38.46% |
| Q3 2024 | 2024-09-30 | $11,000 | −$3,000 | −21.43% |
| Q2 2024 | 2024-06-30 | $11,000 | −$4,000 | −26.67% |
| Q1 2024 | 2024-03-31 | $13,000 | −$1,000 | −7.14% |
| Q3 2023 | 2023-09-30 | $14,000 | −$2,000 | −12.50% |
| Q2 2023 | 2023-06-30 | $15,000 | −$1,000 | −6.25% |
| Q1 2023 | 2023-03-31 | $14,000 | −$2,000 | −12.50% |
| Q3 2022 | 2022-09-30 | $16,000 | $1,000 | +6.67% |
| Q2 2022 | 2022-06-30 | $16,000 | $1,000 | +6.67% |
| Q1 2022 | 2022-03-31 | $16,000 | $7,000 | +77.78% |
| Q3 2021 | 2021-09-30 | $15,000 | — | — |
| Q2 2021 | 2021-06-30 | $15,000 | — | — |
| Q1 2021 | 2021-03-31 | $9,000 | — | — |
Entera Bio depreciation and amortization trends
Over the last five fiscal years, Entera Bio's depreciation and amortization decreased from $225,000 to $30,000, a change of −$195,000. The latest reported quarter, Q2 2026, shows $9,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗